LYB004

recombinant zoster vaccine · Guangzhou Patronus Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LYB004, covering 2025-03-13 to 2025-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older [Phase 1]